Susquehanna International Group’s Vaxart VXRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-94,100
Closed -$80K 13352
2024
Q3
$80K Buy
94,100
+79,800
+558% +$61K ﹤0.01% 11174
2024
Q2
$9.58K Buy
+14,300
New +$11.9K ﹤0.01% 11781
2023
Q1
Sell
-64,500
Closed -$61.9K 13579
2022
Q4
$61.9K Sell
64,500
-51,700
-44% -$73.1K ﹤0.01% 11278
2022
Q3
$253K Sell
116,200
-168,100
-59% -$580K ﹤0.01% 10250
2022
Q2
$995K Buy
284,300
+29,100
+11% +$109K ﹤0.01% 6548
2022
Q1
$1.29M Sell
255,200
-151,800
-37% -$769K ﹤0.01% 6508
2021
Q4
$2.55M Sell
407,000
-180,700
-31% -$1.23M ﹤0.01% 4954
2021
Q3
$4.67M Sell
587,700
-81,900
-12% -$674K ﹤0.01% 4073
2021
Q2
$5.01M Sell
669,600
-119,500
-15% -$834K ﹤0.01% 4031
2021
Q1
$4.77M Sell
789,100
-259,000
-25% -$1.99M ﹤0.01% 3991
2020
Q4
$5.99M Buy
1,048,100
+365,100
+53% +$2.32M ﹤0.01% 3154
2020
Q3
$4.54M Buy
+683,000
New +$6.08M ﹤0.01% 3180

Other funds holding VXRT

Susquehanna International Group's VXRT Position: Q3 2025 in Review

Susquehanna International Group sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 232,574 shares — an estimated $105K sold.

Susquehanna International Group first reported a position in VXRT in Q1 2014 and held it in 26 quarters. The position peaked at $11.6M in Q2 2021. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • Susquehanna International Group reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • Susquehanna International Group sold 232,574 Vaxart shares in Q3 2025, an estimated $105K.
  • Susquehanna International Group first reported a position in Vaxart in Q1 2014 and held it in 26 quarters.
  • Susquehanna International Group's Vaxart position peaked at $11.6M in Q2 2021.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.